JBHT
65
2
KR
37
-5
WAT
49
2
EQIX
64
5
APA
53
5
AMAT
52
3
MAR
71
3
DUK
52
-5
DTE
38
-4
CAH
63
3
CHRW
82
3
ZION
71
2
PH
62
2
CL
58
2
RSG
47
2
VRTX
53
5
NUE
58
7
MHK
43
-2
SCHW
64
6
EBAY
53
3
JBHT
65
2
KR
37
-5
WAT
49
2
EQIX
64
5
APA
53
5
AMAT
52
3
MAR
71
3
DUK
52
-5
DTE
38
-4
CAH
63
3
CHRW
82
3
ZION
71
2
PH
62
2
CL
58
2
RSG
47
2
VRTX
53
5
NUE
58
7
MHK
43
-2
SCHW
64
6
EBAY
53
3
Financhill
Back

Franklin Responsibly Sourced Gold ETF Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
78

FGDL
Franklin Responsibly Sourced Gold ETF

Last Price:
$59.07
Seasonality Move:
5.72%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.95
Seasonality Move:
25.93%
Buy
78
Franklin Responsibly Sourced Gold ETF (FGDL) is a Buy

Is Franklin Responsibly Sourced Gold ETF a Buy, Sell or Hold?

  • The current Franklin Responsibly Sourced Gold ETF [FGDL] share price is $57.99. The Score for FGDL is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • FGDL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FGDL Stock Price Chart

What is Franklin Responsibly Sourced Gold ETF's stock price today?

  • The Franklin Responsibly Sourced Gold ETF share price today is $57.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FGDL is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

FGDL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.88 Buy
Relative Strength Index (14 RSI): 69.29 Buy
Chaikin Money Flow: 12707 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.89 - 57.31) Buy
Bollinger Bands (100): (47.12 - 56.02) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

FGDL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.49 Buy
20-day SMA: 56.53 Buy
50-day SMA: 55.35 Buy
200-day SMA: 47.5 Buy
8-day EMA: 57.47 Buy
20-day EMA: 56.63 Buy
50-day EMA: 54.92 Buy
200-day EMA: 48.22 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Franklin Responsibly Sourced Gold ETF Earnings Growth & FGDL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Franklin Responsibly Sourced Gold ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):